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Fig. 1: Image showing devices and tools for femoral artery cannulation and cremaster 
muscle preparation.  
Fig. 2: Image showing the femoral neurovascular bundle in a mouse. From medial to 
lateral: femoral vein, femoral artery, and femoral nerve. 
Fig. 3: Representative example of left femoral artery cannulation in different 
magnifications. 
Fig. 4: Representative example of the mouse cremaster muscle tissue following 
microsurgical preparation in different magnifications. 
Fig. 5: Representative example of the mouse following femoral artery cannulation via 
the femoral catheter and microsurgical preparation of cremaster muscle before 
intravital microscopy. 
Fig. 6: Representative shot of intravital microscopy showing cremasteric 
microvasculature, namely arteriole and venule immediately after injection of 
fluorescently stained stem cells (picture captured under 20x Olympus LUC Plan FLN- 
water immersion objective).   
Fig. 7: Quantitative analysis of c-kit+ cells showing rolling in control groups. 
Fig. 8: Quantitative analysis of c-kit+ cells showing rolling in control groups and TLR 
knockout groups 
Fig. 9: Quantitative analysis of c-kit+ cells showing rolling in experimental groups. 
Fig. 10: Representative picture of intravital microscopy showing rolling stem cell in 
postcapillary venule of the cremaster muscle (picture captured under 20x Olympus LUC 
Plan FLN- water immersion objective).    
Fig. 11: Quantitative analysis of c-kit+ cells showing firm adhesion in control groups. 
Fig. 12: Quantitative analysis of c-kit+ cells showing firm adhesion in wildtype mice 
and TLR knockout groups. 
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Fig. 13: Quantitative analysis of c-kit+ cells showing firm adhesion in experimental 
groups. 
Fig. 14: Representative Picture of Intravital microscopy exhibiting adherent stem cell 
in postcapillary venule of the cremaster muscle (picture captured under 20x Olympus 
LUC Plan FLN- water immersion objective).   
Fig. 15: Quantitative real-time PCR analysis for TNF-α gene expression in wild type 
mice and TLR knockout groups.  
Fig. 16: Quantitative real-time PCR analysis for TNF-α gene expression in 
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1.1 The Heart and Stem cell 
 
 
The idea that the adult heart to be unable to regenerate has been revised through 
studies that have demonstrated the existence of de novo myogenesis in the heart with 
different range of potential (Laflamme & Murry, 2011). This new view opened a 
remarkable therapeutic option for treating the injured heart. Cardiac regeneration 
might be through either dormant inhabitant cells or migrated from bone marrow in 
case of recruitment via injured myocardium or transplanted. The issue surrounds with 
controversy, to which extent the stem cells are able to regain the function of the 
heart, whether the stem cells directly differentiate to contractile myocardium and 
replacing dead cells or through other mechanisms support regeneration like paracrine 
effect and angiogenesis (Lyngbæk, Schneider, Hansen, & Sheikh, 2007). 
 
Stem cells are defined as cells able of self-proliferation as well as differentiation to 
functionally active cells (Weissman, 2000).  
According to the root of development stem cells can be categorized into two groups: 
1. Embryonic stem cells which are originated from the inner cell mass of early 
embryos with a capacity of formation of mesoderm, endoderm, and ectoderm.  
2. Adult stem cells which are distributed in diverse tissues and has the ability to give 
rise to at least one sort of functionally developed offspring. Adult stem cells were 
originally supposed to possess restricted differentiation range, but the studies 
exhibited the divergence of differentiation into endodermal, mesodermal and 
ectodermal ancestry cells, such as induced pluripotent stem cell that can be formed 
from different somatic cells. Stem cell can be classified according to the spectrum of 
differentiation into Totipotent, Pluripotent, Multipotent, and Unipotent. Totipotent 
stem cell carries the broadest spectrum of cellular production like fertilized oocyte, 
which gives rise to all three germ layers, mesoderm, endoderm, and ectoderm, in 
addition to the future placenta for maintenance of the embryo. Pluripotent stem cells 
like inner cell mass of blastocysts (days 4-14 after fertilization) are capable of 
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formation of mesoderm, endoderm, and ectoderm without extra-embryonic tissues. 
Multipotent stem cells have the capacity to produce all cell sorts in one specific 
lineage. Unipotent stem cells can give rise to just one cell lineage (Sobhani et al., 
2017).  
 
A prominent type of adult stem cells is bone marrow stem cells (Sobhani et al., 2017).  
Hematopoietic stem cells are essential in the development of the hematolymphoid 
system, perpetuation, and reproduction (Weissman, 2000).  
Preclinical studies showed that Bone marrow stem cells are capable of producing cells 
other than blood cells and have competency to differentiate into different types of 
cells such as skin (Kataoka et al., 2003), skeletal muscle (Ferrari et al., 1998) blood 
vessels (Asahara et al., 1999) hepatocytes (Lagasse et al, 2000) and cardiomyocytes 
(Orlic et al., 2001).  
 
The heart possesses extremely limited adaptive capacity in response to injury (Keith & 
Bolli, 2015) and self-regeneration appears to poorly compensate myocardial loss after 
myocardial insult (Zhang, Mignone, & MacLellan, 2015), this might be because the 
heart possesses minimal number of internal stem cells (Beltrami et al., 2003), despite 
this it is of profound importance to find out that there is sign of regeneration in the 
human heart (Bergmann et al., 2009). 
Based on findings in preclinical studies, therapeutic stem cell application in many 
clinical trials has been established with promising results (Hare et al., 2012; Chugh et 
al., 2012).   
Various routes for stem cell transplantation have been described, such as delivery in 
the coronary artery (Janssens et al., 2006) or direct injection in the myocardium as in 
our institution in the PERFECT clinical trial (Donndorf, Kaminski, Tiedemann, Kundt, & 
Steinhoff, 2012). 
 
The POSEIDON randomized trial reported that Transendocardial injection of allogeneic 
and autologous MSCs revealed to interface with ventricular remodeling and improved 
functional ability and quality of life (Hare et al., 2012). 
In the SCIPIO Trial utilizing intracoronary infusion of c-kit+ cells, the observed 
improvement in LVEF was around 7.7% after four months and rising to around 13.6 % 
after one year of the stem cell application. More detailed estimation of regional EF 
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showed enhancement of local function, which accompanied by shrinkage of infarct 
size from 30.4 ± 5.1 g at baseline to 23.5 ± 3.7 g at four months and 22.6 ± 5.5 g at 
12 months respectively after stem cell infusion. This reduction in infarct size 
concomitant with apprise in living myocardial tissue + 11.6 g at four months and + 
31.5 g at 12 months after Stem cell therapy (Chugh et al., 2012).   
 
 
1.2 Stem cell homing 
 
 
The milieu of stem cell implements crucial influence on how effectively this repair 
system can regenerate the damaged myocardium. Generally, through three ways stem 
cell therapy can be translated: 1. Autologous transplantation, 2. Allogeneic 
transplantation, and 3. Enhancement of resident cardiac stem and progenitor cells 
(Wang, Chen, Houser, & Zeng, 2013). 
After implantation, the stem cells are facing in the initial step the challenge of survival. 
Microenvironmental difficulties like inflammation, lack of blood supply, and or 
apoptosis might be the causes of death of around 90% of transplanted cells within 
one week of application. After engraftment, around 1% of cells survive a period of 4 
weeks (Zhang, Wang, Li, Duan, & Yang, 2013). 
Acute coronary syndrome induces attraction of a number of diverse bone marrow 
stem cells through raised production of chemoattractants including cytokines, 
chemokines, kinins, bioactive phospholipids, growth factors, and the complement 
cascade. The mobilized stem cells comprise endothelial progenitor cells, hematopoietic 
stem cells, circulating angiogenic cells, pluripotent very small embryonic-like cells and 
mesenchymal stromal cells. It has been shown that the mobilized CD34+ (known as a 
marker of endothelial progenitor cells) cells exhibit increased levels of CXCR4, LFA-1 
(Lymphocyte Function-Associated Antigen 1), VLA-4 (Very Late Antigen-4) and ICAM-1 
(Intercellular Adhesion Molecule 1) receptors, which basically induces homing of these 
cells in the damaged region. As a result of myocardial damage in acute coronary 
syndrome, the level of inflammatory mediators increases. Many of these mediators are 
chemoattractants to promote migration of bone marrow stem cells to the site of 
injury. Circulating stem and progenitor cells express several receptors for chemokines, 
11 
 
cytokines and growth factors. Different pathways are involved in chemotactic response 
of stem cells to the increased level of inflammatory mediators at the site of injury 
(Wojakowski, Landmesser, Bachowski, Jadczyk, & Tendera, 2012). A pivotal factor in 
retaining of stem cells in the bone marrow is stromal-derived factor-1 (SDF-1, also 
termed CXCL12) through interaction with its receptor CXCR4 (C-X-C chemokine 
receptor type 4). This Receptor highly expressed on hematopoietic and other stem 
cells. Activated SDF-1 at the site of injury is an essential chemoattractant for BM-
derived cells exhibiting CXCR4 (Borlongan, 2011).  
 
Numerous other chemotactic routes also involved in stem cell homing such as stem 
cell factor–CD117 (c-kit factor), VEGF–VEGFR (Vascular Endothelial Growth Factor- 
Vascular Endothelial Growth Factor Receptor), hepatocyte growth factor–c-met and 
leukemia inhibitory factor– leukemia inhibitory factor receptor. Furthermore, there are 
several factors affecting stem cell mobilization, including age, related cardiovascular 
risk factors like diabetes mellitus, and medication. These factors influence functional 
potency and the number of stem cells. Distorted Endothelial regeneration in diabetic 
patients might be as a result of decreased endothelial NO synthase-derived nitric oxide 
(NO) production. On the other side, some factors enhance stem cell mobilization, such 
as the use of statin improves stem cell migration and the ability of neovascularization. 
Additionally, physical exercise induces the release of VEGF, increases stem cell 
mobilization  (CD34+/CD45+ and CD133+/CD45+) and improves the migratory ability 
of these cells   (Wojakowski, Landmesser, Bachowski, Jadczyk, & Tendera, 2012). 
 
Moreover, in stem cell homing, adhesion molecules are found to have a crucial role. 
For example, P- and E-selectin are crucial for initial tethering and 'Rolling' of 
hematopoietic stem cells and progenitor cells along the endothelial wall of blood 
vessels. As a next step, cellular 'Adhesion' and transendothelial migration is 
mediated through Integrin molecule (Sahin & Buitenhuis, 2012).   
 
Under normal conditions, hematopoietic stem and progenitor cells present in 
circulating blood with circadian change. Stress situation like inflammation is leading to 
mobilization of more stem cells. It seems that this recruitment is part of the response 
to danger signaling under the setting of the innate immune system for protection, 
maintenance as well as regeneration of body tissues and organs.  TLR has been 
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identified as a new player in stem cell trafficking (Ratajczak et al., 2010). For example, 
Rossini et al. reported that cardiac c-kit+ stem cells migration and proliferation are 
enhanced through HMGB-1 (a TLR ligand) (Rossini et al., 2008).    
 
 
1.3 Ischemia-reperfusion injury 
 
The ischemia-reperfusion injury occurs in many diseases like in myocardial infarction, 
cerebral stroke, renal and intestinal ischemia, and also in relation to cardiovascular 
surgeries (Arumugam et al., 2009). The consequences of ischemia-reperfusion injury 
may go beyond the affected tissue leading to multiple organ failure (Park, Kim, Brown, 
D'Agati, & Lee, 2011). 
Ischemia is the most common cause of cardiac injury due to interruption of myocardial 
perfusion either long-lasting, which results in permanent tissue damage or short-
lasting. In the latter case, restoration of blood flow leads to another type of injury 
named “reperfusion injury.” The end result of diverse cardiac diseases is an 
irreversible cardiac failure, and Immune system may play a decisive role in every step 
of cardiac disease development (Epelman, Liu, & Mann, 2015). 
The injury resulting from ischemia-reperfusion enhances an inflammatory response 
referred as sterile inflammation (Eltzschig & Eckle, 2011), in which the reaction 
happens without the involvement of any pathogenic factors (Epelman, Liu, & Mann, 
2015). 
Various changes at cellular level happen as a result of myocardial ischemia-
reperfusion: firstly 'no-reflow' phenomenon in which ischemic-reperfused endothelial 
cells induce leukocyte accumulation via an exhibition of adhesive molecules. Secondly, 
after reperfusion, the viable myocardium shows temporary impairment in its function 
because of myocardial hibernation, also known as "stunning." Thirdly, the injured 
tissue is liable to arrhythmia. Fourthly, the ongoing progression of tissue damage is 
continuous even after the reestablishment of blood flow. During reperfusion a cascade 
of adverse effects is taking place, starting with increasing intracellular Ca2+ 
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concentration with the commencement of proapoptotic signalings like cytochrome c or 
Diablo homolog (Arslan, De Kleijn, & Pasterkamp, 2011).  
Different ways of cell death would be induced as a consequence of Ischemia-
reperfusion injury, like necrosis and apoptosis. Necrosis leads to rupture of these cells 
due to swelling of organelles and release of intracellular components which are 
remarkably enhancing factors for cytokine generation and attraction of inflammatory 
cells. On the other hand, apoptosis is characterized by internal programming leading 
to cellular regression with retaining membrane until late in the process (Hotchkiss, 
Strasser, McDunn, & Swanson, 2009).  
As a result of cellular death the released intracellular matrix to extracellular, which are 
danger-associated molecular patterns (DAMPs) such as HMGB-1 (Hoebe et al., 2003) 
to neighbor cells and to circulating cells to stimulate Toll-like receptors (TLRs) and 
consequent production of inflammatory cytokines (Arslan, De Kleijn, & Pasterkamp, 
2011). 
The induced inflammatory mediators enhance neutrophil infiltration to the affected 
region leading to endothelial damage by the production of reactive oxygen species 
(ROS), proteases, cytokines, and lipids. Neutrophil invasion to the site of injury related 
to aggravation of cardiac damage and prevention of this infiltration seems to have 
guarding effect. On the other hand, it has been shown that inflammatory cells and 
cytokines are involved in cardiac repair. It is of profound importance to apply 
treatment aiming in protecting the heart from damage and enhancing the healing 
(Timmers et al., 2012). 
 
1.4 Toll-like receptors 
 
 
Pattern recognition receptors (PRRs) are critical members of the innate immune 
system in detecting exogenous molecules from infectious agents referred as 
pathogen-associated molecular patterns (PAMPs) or endogenous danger signals 




Four groups of PRRs have been recognized. These groups comprise Toll-like receptors 
(TLRs), C-type lectin receptors (CLRs), Retinoic acid-inducible gene (RIG)-I-like 
receptors (RLRs) and NOD-like receptors (NLRs) (Takeuchi, O., & Akira, S., 2010). 
TLRs are one of the most studied members of PRRs.  
 
Toll gene was first described in 1985 by Christiane Nüsslein-Volhard from the Max 
Planck Institute in Tübingen. She found that this gene plays a prominent role in early 
embryonic development of Drosophila. Later, scientists from Hoffmann’s laboratory in 
Strasbourg found that the Toll gene is of profound importance in the immune system 
of Drosophila. Then, Ruslan Medzhitov and Charles Janeway at Yale University 
identified that the mammalian possesses Toll-like receptor, which upon activation 
produces NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) in a 
similar way to Toll in Drosophila. Uncovering new mechanisms of TLRs engagement in 
many infectious diseases and inflammatory responses made them a valuable family 
member of PRRs. TLRs are involved in the pathophysiology of many diseases, 
including cardiovascular diseases (Hansson & Edfeldt, 2005). 
 
10 TLRs are present in humans. Different types of cells are expressing TLRs, including 
endothelial cells and cardiomyocytes (Ha, Liu, Kelley, Williams, & Li, 2013). 
TLRs are transmembrane proteins (Kawai and Akira, 2010), which exert their effects 
after stimulation through intracellular adaptors including: MyD88 (myeloid 
differentiation primary response protein), TIRAP (TIR domain-containing adaptor 
protein), TRIF (TIR-domain-containing adaptor inducing interferon β), and TRAM 
(TRIF-related adaptor molecule) (Frantz, Ertl, & Bauersachs, 2007). 
 
TLRs conduct signaling predominantly through two main downstream pathways, 
MyD88, and TRIF pathways. All TLRs are adopting MyD88-dependent pathway with 
the exclusion of TLR3, which in turn resulting in excitation of nuclear factor-kappa B 
(NF-kB) and mitogen-activated protein kinases (MAPKs) to produce inflammatory 
mediators. Activation of TRIF-dependent Pathway can be done through TLR3- and 
TLR4-triggering, enhancing interferon regulatory factor (IRF) 3 and NF-kB for 
promoting type I interferon (interferon α/β) and inflammatory mediators. TIRAP and 
TRAM are acting as organizing accessories that connect TRIF and MyD88 to TLRs. 
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TIRAP associates MyD88 to TLR2 and TLR4. TRAM recruits TRIF to TLR4. TLR4 is the 
only TLR that utilizes all four adaptors (Kawai and Akira, 2010).  
 
Evidence shows that TLRs (Chen et al., 2017) with associated ligands like HMGB-1 
(Tsung et al., 2005) and intracellular adaptors (Ye et al., 2016) play a crucial role in 
mediating inflammatory response after ischemia-reperfusion injury.  
Recently has been recognized that TLRs enrolled in stem cell reparative mechanisms.  
Limana et al. showed recovery of cardiac performance through the application of TLR-
ligand (HMGB-1) in the peri-infarcted left ventricle at four h after ischemia via 
enhancement of endogenous cardiac c-kit+ progenitor cells proliferation and 
differentiation (Limana et al., 2005).  
The exact underlying pathophysiology and way of the intervention of TLRs and 
associated signaling pathways related to stem cell activity in combination with 
ischemia-reperfusion injury demand more clarification and detailed studies.   
 
1.5 TNF-α  
 
 
Myocardial ischemia-reperfusion injury stimulates TLRs to induce several cytokines, 
which in turn play a crucial role in the regulation of inflammation. One of these critical 
cytokines is TNF-α (Takeishi & Kubota, 2009). Under normal physiological condition, 
the cardiomyocyte does not express TNF-α (Chen et al., 2011).    
TNF-α was first described in 1975 as an antitumor agent (Carswell et al., 1975). This 
cytokine beside its common name also referred as endotoxin-induced factor in serum, 
cachectin, and differentiation-inducing factor. TNF group, to which TNF-α belongs, 
consists of numerous essential cytokines participating in mechanisms of tumorlysis, 
apoptosis, and regulation of inflammation. This family comprises TNF-alpha (TNF-α), 
TNF-beta (TNF-β), CD40 ligand (CD40L), Fas ligand (FasL), TNF-related apoptosis 
inducing ligand (TRAIL), and LIGHT (Chu, 2013).  
TNF-converting enzyme translates membrane-associated TNF-α (mTNF-α) to secreted 




The induced TNF-α signaling has been showed to be crucial in maintaining 
homeostasis, though overactivation of TNF-α leads to drawback effects (Cicha & 
Urschel, 2015).   
TNF-α is a well-known cytokine released during a stressful situation. Both destructive 
and constructive roles of this inflammatory mediator were reported. This bidirectional 
action may be demonstrated through its different receptors, TNFR1 and TNFR2. The 
studies showed that TNF-α exerts adverse impact via TNFR1, while affirmative action 
through TNFR2 stimulation (Jiang & Liao, 2010).  
In the setting of therapeutic stem cell application, it has been found that TNF-α plays a 
vital role in stem cell–endothelial interaction (Kaminski et al., 2008). 
 
2. Aim of the research 
 
 
Our research aimed to clarify the role of TLR2 and TLR4 and their secondary 
messengers in stem cell trafficking after stem cell injection using selective knockout 
mice for TLR2 and TLR4 receptors and associated intracellular pathways of MyD88 and 
TRIF in a well-established intravital microscopic examination in the cremaster muscle 
model. In order to provide similar ambient to myocardial injury following ischemia and 
reperfusion, we applied a sequence of 15 min ischemia followed by 15 min reperfusion 
in the cremaster muscle of the mouse.  
In this study, we wanted to observe the migratory behavior of stem cells in relation to 











3. Material and Methods 
 
 
3.1 Animals of experiments 
 
 
The study is carried out according to the animal welfare and permission from the State 
Office for Agriculture, Food Safety and Fishing in Mecklenburg Vorpommern/Germany 
under file number LALLF M-V/TSD/7221.3-1.1-111/12. 
The experimental animals were supplied from Charles River Company (Sulzfeld, 
Germany). All animals were male mice. The genetic background of the control group 
was C57BL/6J. To minimize differences between experimental groups, the knockout 
mice had the same original background race of the control group. The following 
knockout mice were investigated:  
- Toll-like receptor 4 knockout with strain name B6.B10ScN-Tlr4lps-del/JthJ 
- Toll-like receptor 2 knockout with strain name B6.129-Tlr2tm1Kir/J 
- MyD88 knockout with strain name B6.129P2(SJL)-Myd88tm1.1Defr/J 
- TRIF knockout with strain name C57BL/6J-Ticam1Lps2/J 
To prevent influence of changing the breeding environment and emotional 
disturbance, the animals were acclimatized at least for three days after reaching the 
Institute for experimental surgery in Rostock. At the time of operation, the mice were 
at least eight weeks and weighing 20-25g.  
The animals were bred in standardized cages with free access to food and water as 




3.2 Animal groups 
 
 
The experiments established in six groups, and in each group were six mice included: 
1. Group 1 (Control-WT, n=6): negative control group comprises wild type male 
mice of strain C57BL/6J without ischemia and reperfusion. 
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2. Group 2 (IR-WT, n=6): positive control group consists of wild type male mice of 
strain C57BL/6J with the application of a sequence of 15 min ischemia followed 
by 15 min reperfusion of cremaster muscle. 
3. Group 3 (IR-TLR2-ko, n=6): Toll-like receptor 2 knockout male mice (B6.129-
Tlr2tm1Kir/J) exposed to 15 min ischemia and 15 min reperfusion of cremaster 
muscle. 
4. Group 4 (IR-TLR4-ko, n=6):  Toll-like receptor 4 knockout male mice 
(B6.B10ScN-Tlr4lps-del/JthJ), in which the cremaster muscle treated with a 
sequence of 15 min ischemia and 15 min reperfusion. 
5. Group 5 (IR-MyD88-ko, n=6): MyD88 knockout male mice (B6.129P2(SJL)-
Myd88tm1.1Defr/J) with 15 min ischemia and 15 min reperfusion.  
6. Group 6 (IR-TRIF-ko, n=6): TRIF knockout male mice (C57BL/6J-Ticam1Lps2/J) 
exposed to the same sequence of 15 min ischemia followed by 15 min 
reperfusion as in Groups 2,3,4 and 5.  
 
 
3.3 C-kit+ stem cells isolation 
 
 
Bone marrow c-kit+ cells were isolated through utilizing magnetic microbeads coated 
with anti-c-kit monoclonal antibody (CD117 Beads), Miltenyi Biotec MS columns®, and 
the MiniMacs® cell separation system (Miltenyi Biotec, Bergisch Gladbach, Germany). 
The donor male mice were originally C57BL/6J, B6.129-Tlr2Tm1kir/j, and C3H/HeJ. To 
roll out differences in circulating TLRs in order to study the effect of endothelial TLR 




 Sterile hood 
 Centrifuge for tubes 50 ml, 15 ml, and 1.5 ml capacity with below settings: 
 4 °C x 300 G x 10 min 
 20 °C x 300 G x 10 min 
 Refrigerator 4 °C 
 Water bath 
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 Culture hood (incubator) 
 Light Microscope for cell counting 
 Tools and Instruments 
 Icebox  
 4 ml DMEM  in a 15 ml tube  
 Skin scissor 
 Petri dish 
 Pens 
 50ml MACS within 50 ml tube  
 Syringe 5 ml 
 26 G needle  
 Pipette (10 μl-1000 μl) 
 Pipette (0.5 μl -10 μl) 
 Pasteur pipette  
 Cell Filter (40 μm) 
 Boy pipette  
 Tube for boy pipette  
 Trypan blue 
 Paper for cell count  
 Slide for cell count 
 CD117 Beads 
 MACS magnet 
 MACS Column x 2 
 MACS Filter x 1 
 15 ml tube x2  
 Sterile PBS in a water bath  
 1.5 ml tube 
 
Procedure:   
Bilateral femur and tibia of the donor mouse were amputated, dissected, and 
transferred to a sterile hood in 15 ml tube, which contains 4 ml of DMEM. In order to 
prevent temperature fluctuation, which might affect the cells, the isolation procedure 
was undertaken on ice. The bones were placed into a petri dish and kept in DMEM. 
With small scissor the open ends of the bones were cut. Using 26 Gauge needle and 5 
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ml syringe the bone marrows were flushed out with MACS (Magnetic Cell Separation) 
buffer. The procedure was repeated until bones appeared white. Then with 1 ml 
pipette the larger pieces of bone marrow were degraded to be more homogenous, 
keeping in mind the shearing stress. In the next step, the 40 μm cell filter (blue) was 
prepared and rinsed with 1 ml MACS.  Using a Pasteur pipette to filter the cell 
suspension through the cell filter into a fresh 50 ml tube. Thereafter the petri dish was 
rinsed with 5 ml MACS and applied on cell filter. Swirling gently, if no clumps formed 
and appearance was uniform, the cells were sediment in the centrifuge at 300 x G for 
10 min, 4 °C. The supernatant was discarded and resuspended the cells in 1 ml MACS 
and added 14 ml MACS with boy pipette. At this point the cells were counted taking 4 
μl from cells, 6 μl from MACS and adding 10 μl Trypan blue. The whole volume was 20 
μl. Then 10 μl from the mixture has been taken for cell count.  
 
The cells were centrifuged again at 300 x G for 10 min at 4 °C. Meanwhile, CD117 
Beads Volume was calculated. For every 107 mononuclear cells / 1 ml, 20 μl Beads and 
80 μl MACS were added to the cell sediment. First, the larger volume was added, then 
the smaller volume. After homogenization, the cells were placed in the refrigerator at 4 
°C for 15 min.  
For washing the cells, 5 ml MACS was added and then centrifuged at 300 x G for 10 
min at 4 °C. Meanwhile, MACS Isolation was prepared:  30 μm preseparation filter and 
column in separation magnet on MACS multistand over a fresh 15 ml tube. The pre-
separation filter and the column in the separation magnet were rinsed with 0.5 ml 
MACS in order to be prepared for passing cells smoothly through to avoid cell injury. 
The supernatant was resuspended in 0.5 ml MACS. Apply cell suspension on filter and 
column and wait until no more drops come down. Washing was repeated three times 
with 0.5 ml MACS. The negative fraction passed through the filter and the column 
without being caught by the magnet. The positive fraction remained in the column. 
To optimize the isolation, the column with a positive fraction placed on the second 
MACS Column and rinsed three times with 0.5 ml MACS. 
The second column (which contain positive cell fraction) was removed from multistand, 
and away from the magnet, the cells were eluted into a fresh 15 ml tube by forcing 1 
ml MACS buffer using the provided pusher.  
Finally, the isolated cells were counted and centrifuged at 300 x G for 10 min at 14-20 
°C. The total numbers were around 0.4 × 106 c-kit+ cells. 
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3.4 Stem cell staining 
 
 
In order to visualize the stem cells under intravital microscopy (IVM), the cells were 
marked with fluorescent dye Carboxyfluorescein Diacetate-Succinimidyl Ester (CFDA-
SE) (Thermo Fisher Scientific, USA). Sterile PBS was warmed to 25 °C in a water bath. 
At this step, working has been done at room temperature. After centrifuging the 
isolated stem cells, the supernatant was discarded, and resuspension was done within 
500 μl of prewarmed PBS. Then 2 μl of CFDA has been added to the solution (CFDA: 
PBA + cells 2:500). The cells were incubated for 15 min at 37 °C in the incubator. 
Thereafter they were centrifuged at 300 x G for 10 min at 20 °C. Finally, the cells were 
resuspended in 300 μl PBS and prepared for the next step of the experiment. The cells 
were placed in 1.5 ml Eppendorf tube and covered with dark paper to prevent cells 
from exposure to light.   
 
 
3.5 Cremaster muscle preparation  
 
 
The method of opening the cremaster muscle under intravital microscopy is utilized for 
visualization of cremaster microvasculature to its finest branches for studying the 
dynamic changes in these small blood vessels (Baez, 1973). 
 
Checklist: 
- Storage platform for the mouse  
- Two microforceps 
- One microscissor  
- Skin scissor  
- Needle holder  
- 6.0 prolene suture  
- Clamp 
-  2 x 10 cm long plaster threads 
- 2 x NaCl in one ml Insulin syringe  
- 1 Insulin syringe for anesthesia injection  
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- 2 ml tube  
- 12 x plaster strips  
- A femoral catheter (thinned and flushed) 
- cold nitrogen within a special container 
- Icebox 
  
Fig. 1: Image showing devices and tools for femoral artery cannulation and cremaster 
muscle preparation.  
 
Procedure:  
Prior starting the operation, the mouse was anesthetized through intraperitoneal 
injection of Ketamin (Ketanest) 75mg/kg and Xylazin (Rompun) 25 mg/kg. For exact 
preparation of the anesthesia, the below formula was used.   
Mouse in g (weight) x 10 = in microliter from the solution containing Kitamin and 
Xylazin  
Preparation of the solution of Kitamin and Xylazin: 
Ketamin 10 % (100 mg/ml) 
150 μl Ketamin + 850 μl NaCl  
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Xylazin 2 % (20 mg/ml) 
250 μl Xylazin + 750 μl NaCl   
Both mixed in a 2 ml Tube and according to the weight of the mouse, the required 
amount was injected. After a few minutes of narcosis preparing the area of operation 
was undertaken by shaving the left medial thigh, left inguinal region, right testicle and 
right groin. The hair remnants were removed using moistened Q-tip.  
 
To prevent airway blockage, the tongue was put aside and fixated at the angle of the 
mouth.  
The mouse was placed on stage (operation table), and the limbs were fixated. The 
mouse and operation table was placed on a heating plate (Leica HI1220) at 37 °C, to 
avoid hypothermia (Fig. 1). After that under using an operation microscope (Leica 
M651) with tenfold magnification, an incision at the distal part of the left thigh was 
done. The superficial connective tissue was dissected and the whole left femoral artery 
prepared (Fig. 2). The two caudal branches were cauterized. Through attachment to a 
suture material, the medial and lateral superficial adipose tissues were fixated. The 
fatty tissue over the neurovascular bundle was removed. Thereafter the femoral nerve 
accompanying the artery was transected using microscissor. The distal end of the 
femoral vein and artery were ligated. A knot was formed around the proximal part of 
the femoral artery and vein without ligation. At this step, the magnification power of 
microscope was switched to 16 fold. An oblique incision of the femoral artery to about 
1/3 to 1/2 of the vessel diameter was done with microscissor, followed by subsequent 
dilatation of the opening with the tip of the scissor. The prepared catheter (Portex 
non-sterile Polythene Tubing 0.28mm ID, SIMS Portex, UK) was cautiously introduced 
to the femoral artery (Fig. 3). Correct positioning of the catheter was checked through 
blood aspiration and slow injection. Then the proximal knot was slightly tightened to 
secure position of the catheter.   
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Fig. 2: Image showing the femoral neurovascular bundle in a mouse. From medial to 







Fig. 3: Representative example of left femoral artery cannulation in different 
magnifications. 
 
The next step is the preparation of the cremaster muscle. After switching again to 
tenfold magnification power, a skin incision was made at caudal portion of the right 
testicle. The subdermal adipose tissue was carefully removed. The tip of cremaster 
muscle was fixated using 6-0 Prolen (Ethicon, Somerville, New Jersey, USA). The rest 
of surrounding connective tissue was removed and muscle exposed proximally as 
much as possible. An incision was done on the anterior surface of the muscular sac 
and then proximally and distally extended. Respecting the underlying structures, the 
testicular sac was separated from the cremaster muscle. As a next step, the cremaster 
muscle was opened, and the ends were fixated using prolen 6-0 suture material (Fig. 4 
and Fig. 5). It is necessary to keep the cremaster muscle during the whole procedure 
moist, and the catheter should be washed regularly to avoid clot formation within it. In 
case of ischemia-reperfusion, an atraumatic microvascular neurosurgical clamp 
Aesculap FT 250 T (Aesculap, Braun Melsungen AG, Melsungen, Germany) was applied 
to the base of cremaster muscle (proximal vascular bundle) leading to establish 




Fig. 4: Representative example of the mouse cremaster muscle tissue following 






Fig. 5: Representative example of the mouse following femoral artery cannulation via 




3.6 Intravital Fluorescence Microscopy (IVM) 
 
 
 After preparation of cremaster muscle, the mouse was transferred under intravital 
microscopy (IVM).  
 
Procedure: 
Intravital microscopy was performed using an Axio-tech fluorescence microscope (Carl 
Zeiss, Jena, Germany), modified for epi-illumination and connected to a charge-
coupled device (CCD) video camera (Pieper FK 6990A-IQ) Creating a video file via a 
camera-coupled recorder (Panasonic DMR-EX99V). 
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The observation of the cremaster muscle was done with the aid of a water immersion 
objective with 20x Magnification factor (Olympus LUC Plan FLN) and also coupled to 
the camera Screen (Ikegami). 
For contrast-intensification of plasma, 100 µl fluorescent dye Rhodamine 6G was 
injected then followed with flushing of 0.9 % NaCl. The prepared stem cells were put 
in an insulin syringe and attached to the femoral catheter. Thereafter microcirculation 
of cremaster muscle could be visualized after focusing and clarification of the image. 
Then six different clear postcapillary venules randomly selected under 20x blue color 
filter. The recording was started at this moment. The first selected venule was 
focused, and the stem cells were injected (Fig. 6). The recording was done for one 
minute for later analysis. The same recording was repeated for the other venules. After 
recording all six venules, the second step of registration was commenced.  Recording 
started from the first venule for one minute, and respectively the rest venules were 
recorded for further digital analysis. The first round of recording was to view the rolling 
cells. The second round of recording was to visualize the adherent cells. The intravital 
microscopy procedure was recorded on a DVD and labeled with related information. 
After completion of the experiment, the cremaster muscle was removed. Before 
preservation the probe was immersed in PBS in order to be washed from blood and 
hair remnants then dried and after that placed in 1.5 ml tube. After that, it was 
immersed in liquid nitrogen for less than 10 sec. The cremaster muscle was preserved 








Fig. 6: Representative shot of intravital microscopy showing cremasteric 
microvasculature, namely arteriole and venule immediately after injection of 
fluorescently stained stem cells (picture captured under 20x Olympus LUC Plan FLN- 







3.7 RNA Isolation 
 
 
Total RNA was isolated from explanted cremaster muscle tissue through TRIZOL® 
Reagent (Life Technologies, Darmstadt, Germany) as follows: 
Reagents: 
 TRIzol Reagent 
 Chloroform (trichloromethane, methyl trichloride) 
 Isopropyl alcohol (2-Propanol) 
 75% ethanol (in diethylpyrocarbonate (DEPC)- treated water) 
 RNAse-free water (non-DEPC treated) or 0.5% SDS (sodium dodecyl sulfate) 
solution 
 
Before starting with the procedure, the centrifuge was set at 4 °C. 
 Homogenization: 
 The frozen cremaster muscle was degraded means mortar to make a powder-
like substance with the aid of liquid nitrogen 
 The TRIzol reagent was added to the dish (1 ml per 3.5 cm diameter dish) 
 Pipetting was done a few times, and the dish was incubated for 5 min at room 
temperature 
 The solution then transferred to 1.5 ml tube 
 Phase separation: 
 Centrifugation was done at 12.000 x G for 10 min at 4 °C 
 The supernatant containing RNA was collected and transferred to 1.5 ml tube 
 Chloroform was added to homogenate (0.2 ml per 1 ml TRIzol used for 
homogenization) 
 Tubes were shaken vigorously by hand for 15 sec 
 Then incubation room 3 min at room temperature was done 
 Thereafter the solution was centrifuged at 12.000 x G for 15 min. at °C 
 A colorless aqueous upper phase was appeared containing RNA only (around 
60% of the total volume of homogenization) 
 RNA precipitation: 
 The aqueous phase was transferred to a fresh 1.5 ml tube 
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 Isopropyl alcohol was added and mixed (0.5 ml per 1 ml TRIzol reagent used 
for homogenization) 
 The mixture was incubated for 10 min at room temperature 
 After that, the solution was centrifuged at 12.000 x G for 10 min at 4 °C 
 RNA wash: 
 Gel-like pellet supernatant was removed 
 Washing was done with 75% ethanol (1 ml per 1 ml TRIzol reagent used for 
homogenization; 100% Ethanol was diluted in non-DEPC treated water 
 Shaking was done using Vortex 
 Centrifugation at 7500 x G for 5 min at 4 °C 
 The supernatant was removed carefully 
 Redissolving the RNA: 
 Air-dry pellet for 5-10 min 
 The RNA pellet dissolved by resuspension with RNAse-free water (> 15 μl) 
 
 
3.8 cDNA Preparation 
 
 
"Samples were analyzed with NanoDrop1000 (Thermo Scientific, Karlsruhe, Germany) 
to demonstrate consistent quality and to determine RNA concentration" (Donndorf, 
Abubaker, Vollmar, Rimmbach, Steinhoff, & Kaminski, 2017). 
"Reverse transcription of RNA for first-strand cDNA synthesis was done using High 
Capacity cDNA Reverse Transcription Kit (Life Technologies)" (Donndorf, Abubaker, 
Vollmar, Rimmbach, Steinhoff, & Kaminski, 2017). 
 
 
3.9 Real-time PCR 
 
 
"cDNA was then analyzed using quantitative real-time reverse-transcription polymerase 




Amplification and detection were performed with the StepOnePlus™ Real-Time PCR 
System (Life Technologies) in TaqMan Universal Master Mix (Life Technologies) 
according to the instructions of the manufacturer (Life Technologies). cDNA extracts 
were tested in duplicates, and negative controls were included in each assay. Cycle 
thresholds (CT) for single reactions were determined with StepOne™ Software 2.0 
(Applied Biosystems), and the target genes were normalized against RPLP0 
housekeeping gene (formula: ΔCT = CT target - CT RPLP0). Resulting ΔCT of duplicates was 
averaged, and ΔΔCT were obtained using the control group as a calibrator sample 
(formula: ΔΔCT = ΔCT sample - ΔCT calibrator sample). In our study, the 2
-ΔΔCt method was 
employed to analyze the changes in TNF-α gene expression within the experimental 
groups" (Donndorf, Abubaker, Vollmar, Rimmbach, Steinhoff, & Kaminski, 2017). 
 
 
3.10 Digital Analysis of microcirculatory interaction of c-kit+ stem 
cells in vivo 
 
 
"C-kit+ cell behavior along the endothelial lining was considered as ‘rolling’ when a 
more than 50% reduction of cell velocity in combination with the typical cellular ‘stick 
and release’ motion was present. The rolling cells were expressed as percentage of all 
passing cells along a predefined venular distance during 1 min of observation. All the 
cells that showed random brief tethering phenomena were not considered as rolling 
cells. Firm adhesion was recorded when cells did not move for more than 30 s. The 
number of firmly adherent c-kit+ cells was calculated in relation to the endothelial 
surface of the predefined venules (diameter × length × π) and was expressed as 
adherent cells/mm2 endothelial surface. 
 
In order to provide similar microcirculatory conditions within the experimental groups, 
several parameters were measured and taken into careful consideration. Red blood cell 
velocity profile was verified using the line shift method on intravital microscopy 
recordings (CapImage Software, Zeintl, Heidelberg, Germany). The analyses of 
microcirculation also included the measurement of vessel diameter and wall shear 
rates based on the Newtonian definition γ=8 × v/d, where ‘v’ represents the red blood 
cell velocity divided by 1.6 according to the Baker-Wayland factor (Baker and Wayland, 
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1974) and ‘d’ represents the single vessel diameter" (Donndorf, Abubaker, Vollmar, 
Rimmbach, Steinhoff, & Kaminski, 2017). 
 
 
3.11 Statistical analysis 
 
 
"All statistical analyses were performed using Sigma Stat software version 3.0 (SPSS 
Inc., Chicago, IL, USA). Results are given as mean ± S.E.M. Comparisons of the 
groups were executed using one-way analysis of variance (ANOVA) with subsequent 
post hoc multiple Holm–Sidak analysis. In case the data failed normality testing, the 
nonparametric Kruskal– Wallis or post hoc multiple Dunn tests were employed. P-
values <0.05 were considered statistically significant" (Donndorf, Abubaker, Vollmar, 
























4.1 Rolling as an initiation in interaction of stem cells with the 
endothelium  
 
4.1.1 Rolling in Group 1 (Control-WT, n=6) 
 
The percentage of rolling bone marrow stem cells in the postcapillary venules of 
the cremaster muscle in the control group without exposure to ischemia and 
reperfusion was reaching to 17.3±3.9% (Fig. 7). 
 
4.1.2 Rolling in Group 2 (IR-WT, n=6) 
 
The percentage of rolling of stem cells in the postcapillary venules of the 
cremaster muscle exposed to 15 min ischemia followed by 15 min reperfusion 
was significantly higher (67.6±2.3% in IR-WT vs. 17.3±3.9% in Control-WT, 









4.1.3 Rolling in Group 3 (IR-TLR2-ko, n=6) 
 
The percentage of rolling stem cells after ischemia and reperfusion in TLR2-
knockout animals was 46.4± 4.9% vs. 67.6±2.3% in IR-WT, p<0.05 (Fig. 8). 
 
4.1.4 Rolling in Group 4 (IR-TLR4-ko, n=6)  
 
The percentage of c-kit+ cells after ischemia and reperfusion in TLR4-knockout 
mice showing endothelial rolling was 45.3± 4.8% vs. 67.6±2.3% in IR-WT, 




Fig. 8: Quantitative analysis of c-kit+ cells showing rolling in control groups and TLR 
knockout groups.           
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4.1.5 Rolling in Group 5 (IR-MyD88-ko, n=6)  
 
The percentage of rolling progenitor cells after ischemia and reperfusion in 
MyD88-knockout mice was 47.4±4.1% vs. 67.6±2.3% in IR-WT, p<0.05 (Fig. 
9). 
 
4.1.6 Rolling in Group 6 (IR-TRIF-ko, n=6) 
 
The percentage of rolling stem cells after ischemia and reperfusion in TRIF 










                               
Fig. 10: Representative picture of intravital microscopy showing rolling stem cell in 
postcapillary venule of the cremaster muscle (picture captured under 20x Olympus LUC 







4.2 Firm endothelial adhesion  
 
4.2.1 Adhesion in Group 1 (Control-WT, n=6) 
 
The amount of firm adherent c-kit+ cells in postcapillary venules of cremaster 
muscle in the negative control group wildtype animals was 5.6±1.3 cells/mm2 
(Fig. 11). 
 
4.2.2 Adhesion in Group 2 (IR-WT, n=6) 
 
Following application of 15 min ischemia and 15 min reperfusion in wildtype 
mice, the number of bone marrow stem cells exhibiting firm adhesion was 
30.1±9.9 cells/mm2 vs. 5.6±1.3 cells/mm2 in Control-WT, p<0.05 (Fig. 11).  
 
 







4.2.3 Adhesion in Group 3 (IR-TLR2-ko, n=6) 
 
The number of bone marrow stem cells exhibiting firm adhesion in TLR2-
Knockout mice after ischemia and reperfusion was 16.4±4.0 cells/mm2 vs. 
30.1±9.9 cells/mm2 in IR-WT, p<0.22 (Fig. 12). 
 
4.2.4 Adhesion in Group 4 (IR-TLR4-ko, n=6)  
 
The number of c-kit+ cells exhibiting firm adhesion in TLR4-Knockout mice after 
ischemia and reperfusion was 14.6±4.4 cells/mm2 vs. 30.1±9.9 cells/mm2 in 
IR-WT, p<0.22 (Fig. 12). 
 
 
Fig. 12: Quantitative analysis of c-kit+ cells showing firm adhesion in wildtype mice 
and TLR knockout groups. 
 
4.2.5 Adhesion in Group 5 (IR-MyD88-ko, n=6) 
 
The number of c-kit+ cells exhibiting firm adhesion in MyD88- knockout mice 
after ischemia and reperfusion was 9.2±2.2 cells/mm2 vs. 30.1±9.9 cells/mm2 




4.2.6 Adhesion in Group 6 (IR-TRIF-ko, n=6) 
 
The number of bone marrow stem cells exhibiting firm adhesion in TRIF-
knockout animals after ischemia and reperfusion was 14.1±4.6 cells/mm2 vs. 
30.1±9.9 cells/mm2 in IR-WT, p<0.08 (Fig. 13).  
 
 
Fig. 13: Quantitative analysis of c-kit+ cells showing firm adhesion in experimental 
groups. 
 










Fig. 14: Representative Picture of Intra-vital microscopy exhibiting adherent stem cell 
in postcapillary venule of the cremaster muscle (picture captured under 20x Olympus 







4.3 Real-time PCR to quantify the Expression of TNF-α 
 
4.3.1 Real-time PCR in Group 1 (Control-WT, n=3) 
 
The average mRNA expression level of TNF-α in the Control group without 
ischemia and reperfusion was arbitrarily given the value 0 (Fig. 15). 
 
4.3.2 Real-time PCR in Group 2(IR-WT, n=3) 
 
The average mRNA expression level of TNF-α in wild mice treated with 15 min 
ischemia and 15 min reperfusion was 1.81 ± 0.3 fold higher with p<0.05 as 
compared to the untreated control group (Control-WT) (Fig. 15). 
 
4.3.3 Real-time PCR in Group 3 (IR-TLR2-ko, n=3) 
 
The average mRNA expression level of TNF-α in TLR2-knockout mice after 
ischemia and reperfusion was 0.86 ± 0.39 fold higher as in the control group 
(Control-WT) without reaching statistical significance (Fig. 15). 
 
4.3.4 Real-time PCR in Group 4 (IR-TLR4-ko, n=3) 
 
The average mRNA expression level of TNF-α in TLR4-knockout mice after 
ischemia and reperfusion was 2.45 ± 0.47 fold higher as in the control group 






Fig. 15: Quantitative real-time PCR analysis for TNF-α gene expression in wild type 
mice and TLR knockout groups. The average mRNA expression level of TNF-α in 
control tissue was arbitrarily given the value 0 (line). 
 
4.3.5 Real-time PCR in Group 5 (IR-MyD88-ko, n=3) 
 
The average mRNA expression level of TNF-α in MyD88-knockout mice after 
ischemia and reperfusion was 0.91±0.1 folds higher in control group (Control-
WT) resulting in p<0.05 as compared to the positive control group (IR-WT) 
(Fig. 16). 
 
4.3.6 Real-time PCR in Group 6 (IR-TRIF-ko, n=3) 
 
The average mRNA expression level of TNF-α in TRIF-knockout mice after 
ischemia and reperfusion was 4.09±0.73 folds higher with p<0.05 as compared 





Fig. 16: Quantitative real-time PCR analysis for TNF-α gene expression in 























5.1 Experimental model 
 
 
WHO report showed that in 2016, noncommunicable diseases are responsible for 
around 71% of deaths globally. Cardiovascular diseases, chronic respiratory diseases, 
cancer, and diabetes are the most common mortality causes of this group. Around 
17.9 million deaths occurred due to cardiovascular diseases, which are making 44% of 
all noncommunicable diseases (World Health Organization, 2018). Ischemic heart 
disease is the major killer in all socioeconomic groups (Nowbar, Gitto, Howard, Francis, 
& Al-Lamee, 2019). One of the significant complications of ischemic heart disease is 
ischemic cardiomyopathy and heart failure, in which the loss of myocardium, resulting 
in ceasing the functional performance of the heart to pump the blood. Management of 
patients with heart failure is complex, and upon late advancement of the disease 
reluctant to therapy, the heart must be replaced through heart transplantation 
(Bhandari, B., & Masood, W., 2019).  
 
Emerging stem cell therapy brought hope in treating patients with ischemic heart 
failure (Rosenstrauch, D., 2005). Despite recorded beneficial effects, the exact 
underlying mechanisms yet need more detailed studies.  It is essential to conduct 
researches to maximize the positive effects of stem cells. Proper homing seems to be 
the initial step.  
 
For this purpose in our study, we analyzed Stem cell-endothelial interaction exhibited 
in terms of stem cell rolling and adhesion in cremaster muscle microvasculature using 
fluorescent intravital microscopy. 
Using the intravital microscopy in visualizing the cremaster muscle microvasculature 
has been applied primarily in immunological studies demonstrating the leukocyte-
endothelial interaction (Secklehner, Lo Celso, & Carlin, 2017). Studying interplay 
between stem cells and target endothelial via cremaster muscle intravital microscopy 
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has been used in numerous studies in our research groups (Donndorf et al., 2013; 
Kaminski et al., 2008; Furlani et al., 2012). 
 
In treating myocardial ischemia reestablishment of blood supply to the ischemic region 
is leading paradoxically to reperfusion injury. Immune system components like TLRs 
play a crucial rule in mediating ischemia-reperfusion injury (Zuidema & Zhang, 2010). 
Additionally, TLRs found to be important in mediating stem cell-related regeneration 
after ischemia-reperfusion injury (Abarbanell et al., 2010).  
 
In this series of experiments, we modified the cremaster muscle model by adding a 
sequence of 15 min ischemia, followed by 15 min of reperfusion. One of the primary 
goals of this research was to explain the role of TLRs and their intracellular signaling 
pathways in the regulation of stem cell homing. Therefore we used selected knockout 
animals for each TLR2, TLR4, MyD88, and TRIF, in order to establish possible holistic 
approach in the interpretation of crosstalk between stem cell homing and vital 
members of the immune system after ischemia-reperfusion injury.  
 
 
5.2 Stem cells interaction in control groups 
 
 
C-kit+ stem cell-endothelial interaction happened mainly in postcapillary venules of 
cremaster microvasculature. This interaction found to be scarce in the untreated 
control group. The results showed that Stem cell rolling accounted for about 
17.3±3.9%. Moreover, the amount of c-kit+ cells exhibiting firm endothelial adhesion 
was 5.6±1.3 cells/mm2.  
 
The experiments confirmed our basic idea that in the case of ischemia-reperfusion 
injury stem cell-endothelial interaction might be enhanced. We found around 3,9 fold 
increase in stem cell rolling (17.3±3.9% in control-WT vs. 67.6±2.3% in IR-WT with 
p< 0.05) and also a remarkable increase in stem cell firm adhesion (5.6±1.3 




Stem cell interaction increases in some way like the perpetuation of leukocyte 
interaction after ischemia-reperfusion injury (Ozmen, Ayhan, Demir, Siemionow, & 
Atabay, 2008). It is not surprising that part of the inflammatory response is stem cell 
recruitment to promote regeneration and repair mechanisms (Ratajczak et al., 2010). 
The increased level of inflammatory mediators such as TNF-α play a critical role in 
inducing leukocyte rolling and adhesion (Leick, Azcutia, Newton, & Luscinskas, 2014); 
likewise, the stem cell migration depends on these mediators (Kaminski et al., 2008).  
 
Interestingly our results showed that TNF-α mRNA expression boosted after application 
of a sequence of 15 min ischemia followed by 15 min reperfusion to about 1,81 ± 0,3 
fold with p<0.05. It is well known that TNF-α is an important factor in homing of stem 
cell through modifying the expression of adhesive molecules like ICAM-1 and P-Selectin 
(Furlani et al., 2012). Our results are comparable with other studies in demonstrating 
the crucial role of TNF-α in mediating stem cell homing (Prisco et al., 2016; Kaminski 
et al., 2008). 
 
 




Our results exhibited that early stem cell interaction with endothelial cells was reduced 
in TLR receptor 2 and 4 knockout mice. We also observed an apparent decrease in late 
stem cells interaction in the form of firm adhesion in the absence of these receptors 
showing the importance of these members of innate immunity in stem cells homing. 
This finding is in line with the results of earlier study regarding importance of Toll-like 
receptor 2 and 4 for stem cell homing in the context of induction via HMGB-1 (Furlani 
et al., 2012). 
 
Based on knowing two substantial toll-like receptor secondary messengers, MyD88 and 
TRIF, we intended to analyze further which messenger influence stem cells-migration 
to the site of injury after ischemia and reperfusion by using MyD88 and TRIF knockout 
mice. Data showed significant depletion of firm stem cell adhesion to endothelial cells 
absent to endothelial MyD88 pathway. Our results are giving distinctive importance to 
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MyD88 pathway in influencing stem cell migration to the site of injury after ischemia 
and reperfusion. This result is parallel to newly demonstrated finding from Downes et 
al., which reported the neuroprotective effect of TLR-MyD88-dependent signaling after 
a stroke produced via reversible occlusion of middle-cerebral artery of mice (Downes et 
al., 2013). 
 
Both adverse and beneficial influences of TLRs after a myocardial ischemia-reperfusion 
injury have been reported.  Feng et al. (2010) found that MyD88 signaling in bone 
marrow-derived circulating cells produce induction of myocardial ischemia and 
reperfusion insult through neutrophil recruitment (Feng et al., 2010), whereas Wang et 
al. reported the cardioprotective effect of TLR4 - MyD88 in ischemia-reperfusion injury 
mediated through iNOS- and sGC-dependent mechanisms (Wang et al., 2011).  
 
A protective role of TLRs becomes even more prominent in the framework of stem cell 
application. Preconditioning of stem cells through activation of TLRs via ligands before 
transplantation enhances survival of these cells, which is a crucial part in stem cell 
homing (Ha, Liu, Kelley, Williams, & Li, 2013). Application of TLR ligands like HMGB-1 
in combination with mesenchymal stem cell (MSCs) transplantation induces de novo 
vasculogenesis in myocardial infarcted and boundary zone after acute myocardial 
infarction in rats (Jiang, Wang, Jiang, Niu, & Zhang, 2016). 
 
Our data is in controversy with some studies which registered decreased area of 
myocardial damage in TLR2, TLR4 and MyD88 knockout mice (Arslan et al., 2010; 
Chong et al., 2004; Feng et al., 2008). In order to assimilate these seemingly 
contradicting results, it is essential to take into consideration several aspects. One 
aspect is that both circulating cells and target endothelial cells are expressing TLRs. 
One of the particular goals of our research was to analyze the impact of endothelial-
TLRs. Arslan et al. (2010) showed that circulating TLR2 promotes myocardial ischemia-
reperfusion injury and blockage of TLR2 with OPN-301 minimizes cardiac damage and 
improves the protection of the cardiac performance, whereas in our experiments 
endothelial TLRs showed some positive influences in the context of ischemia and 




Another meaningful aspect of explanation is, that studies, which showed a reduction in 
infarct size using genetic deletion were concerned about the limitation of inflammation 
in order to reduce inflammatory damage and less concerned about repair mechanism, 
which is one of the primary goals of inflammation to restore functional ability of the 
damaged organ. In our study, we tried to expose light on the regenerative side after 
ischemia-reperfusion injury.  
Moreover, Mersmann et al. exhibited that deletion of TLR2 in the long term produces a 
detrimental effect on myocardial remodeling as a long term effect after myocardial 
ischemia-reperfusion injury (Mersmann et al., 2010). Additionally, Kim et al. exhibited 
that myocardial ischemia and reperfusion in inactive TLR4 resulted in smaller infarcted 
area and lowering the production of cytokines without salvation of cardiac performance 
(Kim et al., 2007). One important reason could be impairment of regenerative process 
through lack of competent TLRs. 
 
Reduction of inflammation on one side may be beneficial to downsize the extent of 
damage caused by inflammatory cell invasion, but on the other side may exert a 
negative effect on healing process which is part of the inflammatory process. 
Furthermore, suppression of cellular recruitment to the ischemic damaged area in the 
reperfusion phase might involve the stem cells resulting in impairment of myocardial 
regeneration. That is why a more detailed understanding of inflammation, regeneration 
and close interconnection is required to implement more selective therapy without 
compromising the homeostatic system to achieve lesser damage and improve 

















The molecular pathophysiology behind stem cell homing is not well understood. TLRs 
are known as an essential family member of innate immune system and crucial 
regulator of inflammatory response after ischemia and reperfusion injury. These 
receptors are recently recognized as a new player in stem cell trafficking.  
In our study, we aimed to identify the impact of TLR2 and TLR4 and their intracellular 
signaling routes namely MyD88 and TRIF pathways on stem cell homing.  
We utilized a well-established intravital microscopic examination of the cremaster 
microvasculature. Through the application of 15 min ischemia followed by 15 min 
reperfusion of cremaster muscle, we intended to add more similarity to myocardial 
injury following ischemia and reperfusion.    
Our results showed that ischemia-reperfusion enhances stem cell-endothelial 
interaction in terms of stem cell rolling and adhesion. This enhancement was 
accompanied by increased expression of TNF-α mRNA, a cytokine produced after TLR 
stimulation.  
The c-kit+ stem cells rolling ability was significantly reduced after ischemia and 
reperfusion in TLR2 and TLR4 knockout animals. Additionally a noticeable reduction in 
stem cell-endothelial firm adhesion was observed in animals lacking to TLR2 and TLR4. 
Our Data explains the decisive role of TLR2 and TLR4 in stem cell homing following 
ischemia-reperfusion. 
Our results exhibited the importance of intracellular signaling pathways of TLRs in the 
induction of stem cell homing and showed peculiar significance of MyD88 pathway in 
regulating stem cell trafficking after ischemia and reperfusion.   
The clinical application of our research is that the suppression of TLRs and associated 
signaling pathways through anti-inflammatory medications might exert a drawback 
effect on regenerative mechanisms via disturbing proper stem cell homing. It appears 
to be reasonable that the existence of competent or enhanced TLRs might improve 










1- Artificially applied c-kit+ cells interact with the target organ endothelium. 
2- Ischemia and reperfusion enhance stem cell-endothelial cell interplay.   
3- This stem cell-endothelial interaction mediated through TLR2 and TLR4. 
4- Intracellular signaling of TLRs plays an essential role in stem cell trafficking, with 
emphasis on the MyD88 signaling pathway.   
5- Therapeutic inhibition of TLRs and related signaling may hinder the reparative 
process. 
6- Genetic analysis might be necessary for individuals suffering from ischemic heart 









8. Zusammenfassung in Deutsch  
 
 
Die molekulare Pathophysiologie hinter dem Stammzell-Homing ist bisher noch nicht 
ausreichend  untersucht. TLRs sind als wichtiges Familienmitglied des angeborenen 
Immunsystems und als entscheidender Regulator der Entzündungsreaktion nach 
Ischämie und Reperfusion bekannt. Diese Rezeptoren wurden kürzlich als neue 
Akteure im Stammzell-Homing anerkannt. 
Die Fragestellung der vorliegenden Studie war daher den Einfluss von TLR2 und TLR4 
und ihrer intrazellulären Signalwege, nämlich MyD88 und TRIF, auf das Homing von 
Stammzellen zu identifizieren. 
Hierfür wurde eine etablierte intravitalmikroskopische Untersuchung der Cremaster-
Mikrovaskulatur verwendet. Durch die Anwendung einer 15-minütigen Ischämie gefolgt 
von einer 15-minütigen Reperfusion des Cremaster-Muskels beabsichtigten wir 
unserem Model mehr Ähnlichkeit zu Myokardverletzung nach Ischämie und 
Reperfusion zu verleihen. 
Unsere Ergebnisse zeigten, dass die Ischämie-Reperfusion die Stammzell-Endothel-
Wechselwirkung im Hinblick auf das Rollen und die Adhäsion von Stammzellen 
steigerte. Diese Verstärkung wurde von einer erhöhten Expression von TNF-α-mRNA 
begleitet, ein Zytokin, das nach TLR-Stimulation produziert wird. 
Die Rollfähigkeit von c-kit+-Stammzellen war nach Ischämie und Reperfusion bei 
TLR2- und TLR4-Knockout-Tieren signifikant verringert. Zusätzlich wurde bei Tieren, 
denen TLR2 und TLR4 fehlten, eine merkliche Verringerung der festen Adhäsion 
zwischen Stammzellen und Endothelzellen beobachtet. Unsere Daten erklären die 
entscheidende Rolle von TLR2 und TLR4 beim Stammzell-Homing nach Ischämie-
Reperfusion. 
Unsere Ergebnisse zeigten die Bedeutung der intrazellulären Signalwege von TLRs bei 
der Induktion des Stammzell-Homing und eine besondere Betonung des MyD88-
Signalwegs bei der Regulierung der Wechselwirkung zwischen  Stammzellen und 
Endothelzellen nach Ischämie und Reperfusion. 
Die klinische Anwendung unserer Forschung besteht darin, dass die Unterdrückung 
von TLRs durch entzündungshemmende Medikamente die Regenerationsmechanismen 
verhindern könnte, indem das ordnungsgemäße Homing der Stammzellen gestört wird. 
Es erscheint berechtigt, dass das Vorhandensein kompetenter oder verstärkter TLRs 
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die Stammzelltransplantation verbessern und die Gewebereparatur bei Patienten, die 
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1. The mechanisms underlying stem cell homing and its interaction in the target organ 
are not conclusively understood 
 
2. Using a well-established method utilizing the intravital microscopic examination of 
the cremaster muscle is allowing insight into the stem cell interaction in vivo   
 
3. Applying ischemia and reperfusion in the cremaster muscle model adding more 
similarity to the disease picture  
 
4. C-kit+ stem cells rolling and adhesion occurred mainly in the postcapillary venules of 
the cremaster muscle 
 
5. Stem cell-endothelial interaction revealed to be rare in the untreated group 
 
4. C-kit+ cells rolling and adhesion in the affected tissue were raised after ischemia and 
reperfusion 
 
5. Among the members of the immune system, the toll-like receptors influence the 
regenerative mechanisms 
 
6. TLR2 and TLR4 are playing a crucial role in stem cell homing 
 
7. Intracellular signaling pathways of TLRs induce stem cell-endothelial interplay with 
particular importance of MyD88 
  
8. The clinical implication of our study is broad anti-inflammatory or inhibition of TLRs 
and their intracellular signaling pathways may hinder the regeneration 
 
9. In the context of stem cell transplantation presence of intact or enhanced TLR might 
improve progenitor cell survival leading to potentiation of the engraftment and 
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